Skip to main content
Vitaflo VIA Education Portal
  • PHENYLKETONURIA - INFANTS
  • PHENYLKETONURIA - CHILDREN
  • PHENYLKETONURIA - ADOLESCENTS AND ADULTS
  • PHENYLKETONURIA - MATERNAL
  • PHENYLKETONURIA - GMP
  • RARE DISORDERS OF PROTEIN METABOLISM
  • LIPID DISORDERS
  • GLYCOGEN STORAGE DISEASE
  • DRUG RESISTANT EPILEPSY - KETOGENIC DIET
  • DRUG RESISTANT EPILEPSY - K.VITA
  • KIDNEY DISEASE - PAEDIATRIC
  • KIDNEY DISEASE – ADULTS
  • NUTRITION SUPPORT
  • MULTILINGUAL RESOURCES
  • Product calculators and tools
  • CPD REFLECTION TOOL
  • K.VITA CALCULATOR
  • MCT CALCULATOR - LIPID DISORDERS
  • PKU TRIO CALCULATOR
  • KETOGENIC DIET NUTRITIONAL INTAKE TOOL
  • MPKU & LACTATION INTAKE ASSESSMENT
EVENTS
COURSES
BLOGS
Register Login
Source: https://www.vitaflo-via.com/index%2Ephp/disorder-resources/kidney-disease-adults/use-renasteptm-part-dietary-management-acute-kidney-injury

Breadcrumb

  1. Home

The use of Renastep™ as part of the dietary management of Acute Kidney Injury (AKI) | Case Study

Want to access this resource?

REGISTER NOW LOGIN

Description

Case study describing the use of Renastep as on oral nutritional supplement as part of the dietary management of a patient with  Acute Kidney Injury (AKI).

Age:16 years

Gender: Female

Diagnosis: 
Acute Kidney Injury (AKI) with hypercalcaemia. Background of Trisomy 21 and oral aversion.

Relevant History: 
Patient was admitted following routine blood tests having been found to be in AKI. At the time of admission it was unknown if there was a background of Chronic Kidney Disease (CKD) or evolving AKI with unknown cause. The patient was given IV fluids, with serum and urinary investigations. 

Anthropometry:

  • Weight on admission: 27.3kg <0.4th centile* 
  • Current weight: 36.7kg 2nd centile*
  • Height on admission: 128cm 0.4th centiles*
  • Current height: 131.2cm 0.4th-2nd centile*

Feeding history:
Only managing porridge with milk and the occasional yogurt at school. Fluid intake is poor.

Plan: 
Meet energy and protein requirements whilst managing potassium and phosphate intake by reducing the patients intake of cow’s milk and using Renastep and a juice based oral nutritional supplement (ONS) instead.

Nutritional Requirements: 
EAR based on weight on admission = 1201kcal/day
EAR based on ideal body weight of 55.3kg = 2430 kcals/day

Protein: 45.4g/day 
12-20 mmol Ca/day
 

The patient was regularly reviewed in clinic; she was keen to take more porridge at home and had started taking yogurts at school. Her kidney function was improving; her serum potassium and phosphate levels had normalised. Her family were making 5 bowls of porridge per day for her; 3 bowls made with 125mls of Renastep per bowl, 1 with juice-based ONS, and 1 with cow’s milk.

Estimated Dietary Intake: 1398kcal, 38g protein, potassium 117mmol, phosphate 11.3mmol, calcium 19.5mmol.

It was felt that the patient could eat more so the family were advised to make any additional bowls of porridge with a non-calcium-fortified plant-based milk alternative. 

Six months after admission: 

  • Once the patients serum potassium and phosphate levels normalised, Renastep was discontinued.
  • Cow’s milk and yogurts have been increased to meet LRNI for calcium. 
  • Non-calcium fortified plant-based milk alternatives continue.

Estimated Dietary Intake: 1590kcal, 51g protein, 25.4mmol potassium, 22mmol phosphate, 22mmol calcium

  • The use of Renastep enabled a reduction in potassium and phosphate intake which meant the patients serum potassium and phosphate levels returned to be within the reference range. 
  • Renastep is 2kcal/ml which resulted in energy and protein being provided whilst limiting potassium and phosphate intake – this was an ideal way to provide nutrition support for this patient. 
  • Renastep can be taken as a drink, added to foods or used in recipes. .
  • Renastep is convenient and easy to use.
DOWNLOAD

Published

  • 01/06/2023

TAGS

Kidney Disease – Adults

OTHER RESOURCES YOU MAY BE INTERESTED IN

hcp-building-blocks
Case Study

The use of Renastep in adults with chronic kidney disease (CKD)

25/09/2025
A section of a kidney being held
Webinars

Managing Malnutrition in Adult Renal Patients | Webinar Recording

27/04/2022

WE HAVE A WEALTH OF RESOURCES FOR

pku-infant.svg
pku-infant-white.svg

PKU - Infants

pku-children.svg
pku-children-white.svg

PKU - Children

pku-adolescents-adults.svg
pku-adolescents-adults-white.svg

PKU - Adolescents and Adults

mpku.svg
mpku-white.svg

Maternal PKU

pku-gmp.svg
pku-gmp-white.svg

PKU & GMP

Rare disorders
rare-disorders-white.svg

Rare Disorders of Protein Metabolism

Lipid disorder
Lipid disorder white

Lipid Disorders

gsd.svg
GDS white

Glycogen Storage Disease

Ketogenic diet
Ketogenic diet white

Drug Resistant Epilepsy - Ketogenic Diet

k-vita-icon.svg
k-vita-icon-white.svg

Drug Resistant Epilepsy - K.Vita

kidney-disease-child.svg
kidney-disease-child-white.svg

Kidney Disease - Paediatric

kidney-disease-adult.svg
kidney-disease-adult-white.svg

Kidney Disease – Adults

Nutrican support
Nutrican support white

Nutrition Support

The use of Renastep™ as part of the dietary management of Acute Kidney Injury (AKI) | Case Study
  • DISORDER AREAS
  • Phenylketonuria - Infants
  • Phenylketonuria - Children
  • Phenylketonuria - Adolescents and Adults
  • Phenylketonuria - Maternal
  • Phenylketonuria - GMP
  • Rare Disorders of Protein Metabolism
  • Lipid Disorders
  • Glycogen Storage Disease
  • Drug Resistant Epilepsy - Ketogenic Diet
  • Drug Resistant Epilepsy - K.Vita
  • Kidney Disease - Paediatric
  • Kidney Disease - Adults
  • Nutrition Support
  • Multilingual Resources
  • TOOLS
  • CPD Reflection Tool
  • K.Vita Calculator
  • MCT Calculator
  • PKU Trio Calculator
  • mPKU & Lactation Intake Assessment
  • BLOG
  • Blogs
  • CONTACT
  • Contact Us
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • Accessibility Statement
  • Follow us on LinkedIn
Vitaflo - Enhancing Lives Together

Vitaflo International Ltd, Suite1.11, South Harrington Building, 182 Sefton Street, Brunswick Business Park, Liverpool L3 4BQ, UK

©2026 Vitaflo International Limited

® Reg. Trademarks of Societe des Produits Nestle S.A © 2025 All rights reserved Societe des Produits Nestle S.A, Vevey, Switzerland